SILTREX

Welcome to the Brand page for “SILTREX”, which is offered here for In the statement, line 5 after of, damaged skin and is deleted, and of scar is inserted. and in the statement, line 6 after for, scar tissue is inserted, and in the statement line 7 after dermatology, scar tissue care and management is inserted, and in the statement line 7 after products, for use in scar tissue care and management is inserted, and in the statement line 9 after preparations, for use in scar tissue care is inserted.;in the statement, line 1, (nevada corporation) should be deleted, and (delaware corporation) should be inserted.;pharmaceutical preparations and substances for the treatment of [ damaged skin and ] * scar * tissue; pharmaceutical preparations for * scar tissue * skin care; pharmaceutical preparations for use in dermatology *, scar tissue care and management; * dermatological pharmaceutical products * for use in scar tissue care and management; * drug delivery agents in the form of gel-matrix films that facilitate the delivery of pharmaceutical preparations * for use in scar tissue care; * none of the aforesaid * for use in the treatment of wounds or * marketed to plastic or cosmetic surgeons performing implants or tissue expansion or directed for use in plastic or cosmetic surgery related to implants or tissue expanders;.

Its status is currently believed to be active. Its class is unavailable. “SILTREX” is believed to be currently owned by “Vivera Pharmaceuticals, Inc.”


Owner:
VIVERA PHARMACEUTICALS, INC.
Owner Details
Description:
In the statement, line 5 after OF, DAMAGED SKIN AND is deleted, and OF SCAR is inserted. and in the statement, line 6 after FOR, SCAR TISSUE is inserted, and In the statement line 7 after DERMATOLOGY, SCAR TISSUE CARE AND MANAGEMENT is inserted, and In the statement line 7 after PRODUCTS, FOR USE IN SCAR TISSUE CARE AND MANAGEMENT is inserted, and In the statement line 9 after PREPARATIONS, FOR USE IN SCAR TISSUE CARE is inserted.;In the statement, line 1, (NEVADA CORPORATION) should be deleted, and (DELAWARE CORPORATION) should be inserted.;PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF [ DAMAGED SKIN AND ] * SCAR * TISSUE; PHARMACEUTICAL PREPARATIONS FOR * SCAR TISSUE * SKIN CARE; PHARMACEUTICAL PREPARATIONS FOR USE IN DERMATOLOGY *, SCAR TISSUE CARE AND MANAGEMENT; * DERMATOLOGICAL PHARMACEUTICAL PRODUCTS * FOR USE IN SCAR TISSUE CARE AND MANAGEMENT; * DRUG DELIVERY AGENTS IN THE FORM OF GEL-MATRIX FILMS THAT FACILITATE THE DELIVERY OF PHARMACEUTICAL PREPARATIONS * FOR USE IN SCAR TISSUE CARE; * NONE OF THE AFORESAID * FOR USE IN THE TREATMENT OF WOUNDS OR * MARKETED TO PLASTIC OR COSMETIC SURGEONS PERFORMING IMPLANTS OR TISSUE EXPANSION OR DIRECTED FOR USE IN PLASTIC OR COSMETIC SURGERY RELATED TO IMPLANTS OR TISSUE EXPANDERS;
Categories: STATEMENT